Hospital de Cereté will continue to be intervened by the Superintendency of Health

The improvements in infrastructure, the recovery of the portfolio and the opening of services are three of the objectives set by the health authorities in front of the Sandiego de Cereté Hospital, which will continue to be operated for another year.

The Health Superintendent, Fabio Aristizábal Ángel stated that “the intervention ordered at the Sandiego de Cereté Hospital was extended for one year in order to continue working to guarantee the quality and timeliness of the provision of health services and continue with the implementation of the necessary measures to solve financial, legal, administrative and welfare difficulties ”.

It was learned that during this extension, the intervening agent Sandra Milena Jaramillo, will have to work on investment projects, adaptation and remodeling of the infrastructure of the hospital pharmacy, the surgical area and the sterilization center.

“Progress will be made in the works of the San Carlos Emergency Medical Care Center and in the neonatal ICU project to be able to care for high-risk maternal mothers. The hospital already has a 24-hour gynecologist, an intermediate ICU and a pediatric service. The accounting purification process will continue and the work on financial consolidation and portfolio recovery actions will continue, ”explained Aristizábal Ángel.

The authorities highlighted that the institution has been strengthened to care for patients infected by COVID-19, and went from not having ICU beds to having 12, plus another two for intermediate care.

The senior official explained that “due to the management of the special intervening agent, the hospital opened a new respiratory emergency area that operates 24 hours a day and has an office, resuscitation room, 5 observation beds and 8 cubicles for defining behavior.” .

According to the report submitted, the hospital keeps the salaries paid to the personnel up to date and the contributions to social security, parafiscals and the payment to contractors have been met.

“Added to the above is the investment of $ 38 million for the provision of respiratory emergencies, the 7.5% increase in billing during the first quarter of 2020, the restoration of 50 hospital beds, the preventive and corrective maintenance of medical equipment and the automation of sterilization ”, specified the Super Salud.

It is also expected that the installation of a tomograph will be carried out and the completion of the infrastructure works in the admission area.

It should be remembered that due to the critical situation of its finances, and the deficiencies in the provision of services to its users, the hospital was intervened on December 20, 2019.

At that time, there were labor debts with plant workers, contractors, job boards and outsourcing for 11,552 million pesos. Regarding the health services, the authorities revealed that the medical equipment was not maintained, some treatments were started late because medicines were lacking, there were supplies with past expiration dates and there was no regular disinfection in the facilities.


Solidaridad trial will continue with new drugs

Tegucigalpa, Honduras

The Solidaridad clinical trial, which the World Health Organization (WHO) is developing in 30 countries, and of which Honduras is a part, revealed this week that the drugs remdesivir, hidroxicloroquina, lopinavir / ritonavir, and interferon did not reduce mortality from covid-19.

The trial was conducted in 405 hospitals in 30 countries and 11,266 adults were randomized, of which 2,750 patients were administered remdesivir, 954 hydroxychloroquine, 1,411 lopinavir, 651 interferon plus lopinavir, 1,412 interferon alone and 4,088 patients who were in the control group, that is, they were not given any of these drugs.


So far it is the largest clinical study in the world coordinated by the WHO and the University of Oxford.

The results indicate that the drugs have little or no effect in reducing mortality at 28 days or in the hospital evolution of hospitalized patients with covid-19.

Of the 11,266 participants, 1,253 were reported to have died.

Honduras became the third country in Latin America with the highest number of patients investigated, the first two countries were Peru and Brazil.

More than 300 patients from Hospital Atlántida, San Felipe, Instituto Cardiopulmonar, Hospital Militar and Leonardo Martínez participated in the trial. How many of these patients lost their fight against the disease was not reported.

New stage

Marco Tulio Medina, who is one of the principal investigators of the study in the country, said that Solidaridad will continue with new patients to whom other medications will be applied.

“The study continues, we will work with powerful anti-inflammatory drugs, antivirals, monoclonal antibodies and we will continue to evaluate remdesivir,” said the researcher.

The new stage of the clinical trial has just begun under the approval of the Ethics Committee of the Unah, which together with the Ministry of Health support the research. It is also awaiting the arrival of new drugs. More than 300 patients in the country are projected to participate.

Experts stated that Solidarity It is the world’s largest randomized control trial of COVID-19 therapeutic options, which in just six months has generated conclusive evidence of the efficacy of these drugs. “The scientific analysis of these data was carried out at the University of Oxford by one of the most eminent scientists in the world, he is Sir Richard Peto and with the support of Dr. Ana María Henao, who is part of the WHO,” he added. .

Nery Cerrato, Vice Minister of Health and part of the team of researchers, announced that one of the new drugs they will use is acalabrutinib, “It is an antiviral that in preliminary studies shows effectiveness in eliminating the virus.”

He added that they will continue to work to find a effective treatment against disease. “The lesson learned so far is that there is only one safe measure to combat the disease: follow prevention measures, washing hands with soap and water, permanently wearing a mask and physical distancing between people.”


Fox does not believe in the version of the theft of medicines for children with cancer

The ex-president Vicente Fox expressed on Twitter not to believe the statements of the federal government about the oncology drug theft.

When retweeting a publication, the former president said he joined this opinion, after the federal government confirmed the theft of medicines intended for children who are in treatment for Cancer.

During his conference this Monday, the president Andrés Manuel López Obrador described as “very rare” the theft of medicines.

At a press conference, AMLO pointed out that these drugs were brought from Argentina and that “it cost to get them.”

Also read: Sheinbaum describes the theft of drugs for children with cancer in Iztapalapa as “strange”

“Unfortunately, this robbery was carried out, and investigations are being carried out, progress is being made and the entire investigation is going to be concluded, but this drug theft did take place.

“It was difficult for us to get these drugs, we brought them from Argentina, this is very rare; They rob us of a warehouse of these drugs, “he said.

In the National Palace, López Obrador told the parents of these minors that his government is trying to supply these medicines to health centers and hospitals and rejected that their administration is inhumane in this case, “we have feelings.”

AMLO accuses sabotage

President Andrés Manuel López Obrador assured that his government will definitively solve the supply of medicines for children with cancer; He added that there is sabotage by pharmaceutical companies that use patients as a permanent campaign against them.

Also read: AMLO sees sabotage of pharmaceutical companies; goes to supply medicines for children with cancer

“We are seeking to finally solve the supply of medicines for children with cancer, there has been a lot of sabotage on the part of the companies that supplied the medicines to the government, which sold at double, triple the value, they stole money and there was no border between officials and businessmen, there has been a campaign by these companies, they have used the shortage that has to do with children as a permanent campaign of attacks on the government, ”said the president.



Epidemic is on the decline and there is no shortage of medicine, says Alcocer before criticism

Denies shortage of cancer drugs

Senators such as Josefina Vázquez Mota (PAN) and Sylvana Beltrones (PRI) stated that more than 1,600 minors with cancer have died due to not having medicines, so they questioned the measures to guarantee the distribution of drugs.

The secretary acknowledged that cancer is the third leading cause of death and that Mexico leads the infant mortality rate from leukemia. He noted that, according to The National Network of Cancer Registries has identified 22,724 cases of children, adolescents and adults.

“The problem is not recent, I remind you, in 1990 the death toll per 100,000 children between the ages of five and 14 was 1.7 and in 2017 it reached 2.3,” he said, and commented on the measures being taken by the federal government, such as the review of anticancer drugs, of which 214 are registered in the agreement of the General Health Council.

He explained that part of what has been said to parents of children with cancer, who have been treated on several occasions, is that as a result of the health emergency the provider Kemex, from Argentina, with distribution in Mexico through Novag Infancia, has reduced its production and shipments. “To date, the sector demand by said laboratory has been only 42%,” he said.

He recalled the consolidated purchase for 2021. He said that 2,730 keys of 6,640 have already been acquired, and that at the end of August 142 million 594,418 pieces have arrived, which have a demand of 71%; in oncology, the consolidated purchase is equivalent to 62%, although he acknowledged that there are still “uncontrolled” situations, so the authorities have had to buy directly.


They denounce lack of medicine and chemo

Tijuana.-In a deteriorated state of health due to breast cancer, Mrs. Mora May Eraso protested outside the Medical Specialties Unit (Euneme) in Tijuana and denounced the shortage of medicine for patients diagnosed with breast cancer.

We have found that they tell us that if there is chemotherapy in Mexicali, that -the warehouses- are completely full of medicine, but at the time we are requiring it -in Tijuana-, it turns out that there is no

The patient assured that the shortage is serious, because on the day she had a biopsy surgery, the health sector did not have healing material such as adhesive tape and the nurses showed solidarity with the patients and bought the material so as not to suspend the surgery.

When we were already on the second floor, there was from the very least the tape to stick and there was no gauze and the students have been buying healing materials”.

Mora May Eraso has been a breast cancer patient since 2012, she says that in the last two years she returned to the public hospital after a relapse, the cancer returned to her weak body, but on occasions she has had to suspend treatments due to lack of medication in public hospitals in Tijuana.

Subscribe here to El Sol de Tijuana, serious journalism

He mentioned that some of the patients have had to suspend treatment because they do not have the resources to buy the missing medicines, which on average cost more than 20 thousand pesos.

“Many of my colleagues have not been coming to chemotherapies because they need a drug that costs twenty-odd thousand pesos.”

She assures that in recent months the shortage of medicines and supplies is the largest that has been experienced in recent years and like Mora May Eraso, dozens of women continue without it to continue with their chemotherapies.

For its part, the State Health Secretariat reported that 35 patients are being treated for breast cancer in Tijuana’s state public hospitals and they expect the drug to arrive next Friday, October 2.


Order to collect drugs for diabetes by carcinogen

Read this article in English in the Miami Herald.

Authorities ordered a batch of the Type 2 diabetes medicine metformin, Riomet ER, to be collected after laboratory tests revealed it had too much of a NDMA carcinogen.

Sun Pharmaceuticals Industries, also known as Sun Pharma, has released Riomet’s batch number AB06381 of 500 mg metformin hydrochloride tablets for oral suspension. The expiration date is October 20, 2021.

According to the Food and Drug Administration (FDA) Sun Pharma advisory, the drug was sold nationwide, although it did not specify which stores sold the product.

Since May, this is the ninth brand of metformin that has been ordered to collect for having NDMA (N-dimethylnitrosamine). The entire list of what was found appears on the FDA website.

People with questions about this pickup can call Sun Pharma at 800-818-4555, Monday through Friday, 8 am to 5 pm Eastern Standard Time.

Translation of Jorge Posada


Invima alert on injectable ranitidine

The National Institute of Food and Drug Surveillance (Invima) reported the preventive withdrawal of the batches with active principle of “Ranitidine solution for injection”.

The entity explained in the health alert that it found a possible risk due to the “presence of unacceptable levels of
nitrosamine nitrosodimethylamine (NDMA) in the product ”.

The text details that “nitrosamines are classified by the International Agency for Research on Cancer (IARC) as ‘probably carcinogenic'” in a category 2. This chemical can also be found in tobacco smoke, some processed foods and in certain articles of toilet, etc.

What is ranitidine for?

He Invima noted that this medicine is used for the “treatment of gastric or duodenal ulcer”.

Therefore, he asked the users of this product that if they have presented any adverse event associated with consumption, report it immediately through the Invima website at this link.

Injectable ranitidine batch recall

Invima ordered the departmental, district and municipal health secretariats to advance the inspection activities, surveillance and control in establishments where the product can potentially be marketed with the characteristics described.

Said entities have the power to take the measures they deem necessary and destroy the lots you find available for sale to the public. In addition, they must inform Invima if they find the product in commercial channels.

Regarding the Health Service Provider Institutions (IPS) and health professionals, should refrain from marketing and using this product, and if they find stocks they should be quarantined.

Meanwhile, distributors and marketers must refrain from distributing and marketing this medicine or they may be penalized.


Digital Medicine – France fined US $ 524 million pharmaceutical companies Novartis, Roche and Genentech for “abusive practices”

Paris, France. The French Competition Authority imposed a record fine of 444 million euros (US $ 524 million) on the Swiss laboratories Novartis and Roche and the American Genentech, accused of “abusive practices”.

This is the largest collective fine ever imposed by the French authorities on pharmaceutical companies.

In a statement, the French Competition Authority explained that Genentech, Novartis and Roche engaged in abusive “dominant position” behavior in order to preserve the position and price of Lucentis and to curb the cancer drug Avastin, which does not have authorization to be used in macular degeneration.

Lucentis is a treatment for macular degeneration (AMD), an age-related retinal disease, developed by Genentech, whose capital is linked to that of the Swiss groups Roche and Novartis.

However, doctors realized that another Genentech drug, Avastin, had positive effects on AMD and began to prescribe it despite the fact that it does not have a marketing authorization for this disease.

Avastin costs 30 times less than Lucentis. An Avastin injection costs between 30 and 40 euros, compared to 1.16 euros for Lucentis.

According to the competition authority, Novartis “tried to thwart the initiatives of ophthalmologists who, within the framework of their freedom of prescription, decided to prescribe Avastin, outside of its marketing authorization.”

“Novartis, Roche and Genentech were also sanctioned for having applied a series of blocking measures and for having disseminated an alarming and sometimes misleading message to public authorities about the risks associated with the use of Avastin for the treatment of AMD. ”.

Agencia AFP


They order that more thyroid medicines be taken off the market. People with problems have been reported

Read this article in englishs in the Miami Herald.

After several tests and customer complaints about various medical problems, the company Acella Pharmaceuticals ordered two batches of NP Thyroid thyroid tablets to be recalled.

NP Thyroid was ordered to be regoverned for having underpower, the same reason that earlier this month RLC Labs had picked up Nature-Throid and WP Thyroid. In the notice written by Acella, and posted on its website by the Food and Drug Administration (FDA) it is stated that the tablets “could have 87 percent of the amount of levothyroxine (T4) that appears on the label, which is considered low ”.

In simpler terms, this means that the medicine may be too weak to work. As the notice admits, as of Thursday, “Acella had received four reports of adverse events for the numbers of these that are possibly related to this collection.”

These are lots # M327E19-1 for NP Thyroid 15 tablets, 1/4 grains (15 mg), with an expiration date of October 2020; and Lot # M328F19-3 for NP Thyroid 120 Tablets, 2 Grains (120 mg), with an expiration date of November 2020.

Anyone with pickup questions can email or call 888-280-2044, Monday through Friday, 8 am to 5 pm Eastern Standard Time.

Those people who have a medical problem due to this or another medicine, should contact a health professional. You must then report it to the FDA’s MedWatch Adverse Event Reporting Program through the agency’s portal, or through a request that can be obtained by calling 800-332-1088.

Translation of Jorge Posada


Digital Medicine – Vaccination, in times of pandemic

Mexico City. The coronavirus pandemic is dragging on, and to top it off, the peak season for another infectious disease is just around the corner: influenza. At a time when respiratory diseases have gained relevance in the global public interest, medical experts highlighted during the 3rd Flu Summit: ‘Together protecting the world’, the importance of vaccination against the influenza virus as a priority issue on the agenda national.

As a direct result of vaccination, approximately 2 to 3 million lives are saved each year.[iii] However, being one of the most effective public health interventions, 3 to 5 million serious influenza cases are reported worldwide.[iv] and there is an annual estimate of 290,000 to 650,000 respiratory deaths as a consequence of complications from this disease.[v]

“All people are at risk of contracting influenza, since the disease is easily transmitted by coughing, sneezing or talking, however, there are certain groups of people who are more vulnerable to developing complications associated with influenza such as people who they live with diabetes, cardiovascular and respiratory diseases, those over 50, pregnant women and children, among others. These people should be vaccinated as soon as the influenza season begins, starting in October, ”commented Dr. Ricardo Iglesias, from the University of Buenos Aires, Argentina.

After an influenza infection, the risk of a heart attack increases 10 times, while people living with diabetes are 3 to 6 times more likely to be hospitalized and the risk of death from complications is 6 times greater in this group .[vi] “Fortunately, we can face this scenario thanks to vaccination, which today is the most effective way to prevent influenza and especially for people at high risk of complications,” added Iglesias.

For her part, Dr. Flor Muñoz, from Texas Children’s Hospital in the United States of America, mentioned that “Despite all efforts, influenza viruses continue to represent one of the greatest infectious disease challenges worldwide, hence the importance of protecting against influenza and especially now that it will coexist with the circulation of SARS – Cov2 that causes COVID-19 ”. She also stressed that “It is very important to vaccinate the school-age population, since they are considered super-spreaders of the virus to the rest of the community. Only in 2019, this group was the second most affected by influenza, hence vaccination for this population group becomes important during the influenza season that is about to begin ”.

The challenge: recover vaccination schedules

Currently, the world faces multiple health challenges ranging from outbreaks of vaccine-preventable diseases such as measles and diphtheria, to doubts about the benefits of vaccines (reluctance or rejection) that threaten to reverse the progress made. in the fight against vaccine-preventable diseases.[vii]

Due to the COVID-19 pandemic and according to the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF), vaccination coverage rates worldwide have gone down.[viii]. So far in 2020, in Mexico vaccination coverage of children under one year of age decreased by 21% versus the first half of 2019[ix] and only 4 out of 10 children under one year of age have an incomplete vaccination schedule,[x] For this reason, today more than ever and despite the pandemic, it is extremely important to go to vaccinate babies and children following all safety measures since the clinics remain open and the vaccination programs have not stopped.

For his part, Dr. Gary Marshall, Pediatric Infectologist and Chief of the Division of Pediatric Infectology at the University of Louisville School of Medicine, stated that: “Vaccines are among the great achievements that humanity has had and represent one of the safest medical developments in the world, as its main function is disease prevention. On the contrary, resistance to vaccination can lead to significant damage to health and the suspension of vaccination services could become a great threat to life. “

“We continue to face challenges such as access and distrust in vaccines that keep us exposed to threats that could be fatal if not attended to in time, so it is relevant to share scientific information on the subject in order to increase trust and therefore increase vaccination rates ”. Today more than ever and in the face of the panorama that the world is experiencing, we must understand the value of vaccination and make use of all the vaccines that today can help us prevent more than 26 diseases ”, concluded Marshall.

For its part, Sanofi Pasteur reinforced its commitment to protecting public health through the essential supply of influenza vaccine worldwide and reaffirmed its purpose to continue working so that no one suffers or dies from a preventable disease caused by vaccination.

Drafting MD


[i] UNICEF (2020). Immunize the children who need it most, available at:

[ii] WHO (2019). WHO launches new global influenza strategy, available at:

[iii] UNICEF (2020). Immunize the children who need it most, available at:

[iv] WHO (2018). Influenza (Seasonal), available at:

[v] WHO (2019). WHO launches new global influenza strategy, available at:

[vi] Sanofi Pasteur (2020). Influenza is a serious infection that can have unexpected, severe consequences, disponible en:

[vii] PAHO (2019). What are the top 10 health threats in 2019, available at: -2019 & Itemid = 135 & lang = en

[viii] WHO (2020). WHO and UNICEF warn of a decrease in vaccinations during COVID-19, available at: warn-of-a-decline-in-vaccinations-during-covid-19

[ix] General Directorate of Health Information (2019-2020). Dynamic Cubes. Services Granted 2019 and 2020, available at: and

[x] General Directorate of Health Information (2019-2020). Dynamic Cubes. Services Granted 2019 and 2020, available at: and